1. A case of sternal osteomyelitis during treatment with everolimus for recurrent breast cancer
    Kaori Abe et al, 2022, Surgical Case Reports CrossRef
  2. Efficacy and Safety of Lenvatinib in Anaplastic Thyroid Carcinoma: A Meta-Analysis
    Dongmei Huang et al, 2022, Frontiers in Endocrinology CrossRef
  3. Real-world insights into the efficacy and safety of tyrosine kinase inhibitors against thyroid cancers
    Lingyu Li et al, 2022, Critical Reviews in Oncology/Hematology CrossRef
  4. Management of VEGFR-Targeted TKI for Thyroid Cancer
    Tomohiro Enokida et al, 2021, Cancers CrossRef
  5. Anti-Proliferative Effect of Radiotherapy and Implication of Immunotherapy in Anaplastic Thyroid Cancer Cells
    Sabine Wächter et al, 2023, Life CrossRef
  6. Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience
    Nerina Denaro et al, 2022, Journal of Clinical Medicine CrossRef
  7. Targeted Therapy for Anaplastic Thyroid Carcinoma: Advances and Management
    Jiaqian Yuan et al, 2022, Cancers CrossRef
  8. State of the Art in the Current Management and Future Directions of Targeted Therapy for Differentiated Thyroid Cancer
    Horatiu Silaghi et al, 2022, International Journal of Molecular Sciences CrossRef
  9. Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma
    Laurys Boudin et al, 2022, Current Oncology CrossRef
  10. Tracheoesophageal fistula development following radiotherapy and tyrosine kinase inhibitors in a patient with advanced follicular thyroid carcinoma: a case-based review
    Tatiana S. Temperley et al, 2023, Irish Journal of Medical Science (1971 -) CrossRef